Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 6/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | WNT1 | P04628 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | BRAF | P15056 | 2/20 | 0.31 |
| ▸ | CFD | P00746 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12733449 | 0.81 | CYP3A4 (0.50) | CYP3A4CYP2D6TSHRWNT1GSK3B | |
| SCHEMBL9911458 | 0.81 | CYP3A4 (0.50) | CYP3A4CYP2D6TSHRWNT1GSK3B | |
| SCHEMBL12304484 | 0.81 | CYP3A4 (0.50) | CYP3A4CYP2D6TSHRWNT1GSK3B | |
| SCHEMBL20341256 | 0.81 | CTSK (0.46) | CYP3A4CYP2D6CTSKHDAC1PTGER4 | |
| SCHEMBL19661451 | 0.81 | CTSK (0.46) | CYP3A4CYP2D6CTSKHDAC1PTGER4 | |
| SCHEMBL17793277 | 0.77 | CTSK (0.41) | CYP3A4CYP2D6CTSK | |
| SCHEMBL7465935 | 0.77 | CTSK (0.41) | CYP3A4CYP2D6CTSK | |
| SCHEMBL8073741 | 0.77 | CYP3A4 (0.42) | CYP3A4CYP2D6 | |
| SCHEMBL2604731 | 0.76 | CYP3A4 (0.47) | CYP3A4CYP2D6TSHRWNT1GSK3B | |
| SCHEMBL12733399 | 0.76 | CYP3A4 (0.47) | CYP3A4CYP2D6TSHRWNT1GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090162400-A1 | Compositions of influenza viral proteins and methods of use thereof | VAXINNATE CORPORATION | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162400-A1 | Compositions of influenza viral proteins and methods of use thereof | LY96, CD74, HAVCR2 | CYP3A4 4656/4885CYP2D6 4800/4885CTSK 2300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.